Defend 340B Program, Hold Drugmakers Accountable N..

23 i

Defend 340B Program, Hold Drugmakers Accountable Now

Defend 340B Program, Hold Drugmakers Accountable Now

dailypresser.com

Defend 340B Program, Hold Drugmakers Accountable Now

This article explains 340B: what the program does, how drugmakers respond, why critics confuse rebate rules with program rules, and why efforts to weaken 340B benefit pharmaceutical companies more than patients. It walks through the history, the pricing mechanics, the "duplicate discount" confusion, transparency concerns, and the consequences of changing the model from upfront discounts...

Tycka om

Kommentar

Dela med sig